Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06805240 · ClinicalTrials.gov registry record
EvaluatIng Normal Values for traditionaL anorectaL fUnction paraMeters With aIr Charged aNd Solid State HRAM catheTErs ("ILLUMINATE" Study)
A clinical trial of Healthy, sponsored by Laborie Medical Technologies.
- Recruiting
- Registry status
- 81
- Enrollment target
- 3
- Study locations
NCT06805240: Recruiting study of Healthy, sponsored by Laborie Medical Technologies.
NCT06805240 is a study of Healthy that is actively recruiting participants, run by Laborie Medical Technologies. The registered enrollment target is 81 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (87% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06805240, a study of Healthy, is actively recruiting participants, sponsored by Laborie Medical Technologies.
- RECRUITING
- Registry status
- 81 participants
- Enrollment target
- 3
- Study locations
Study Summary
The research study will be conducted to obtain baseline, or "normative" information to compare an air charged HRAM catheter to traditional solid catheter measures using the IAPWG standardized testing protocol and London classification.
Primary Outcome
Functional anal canal length, cm, as measured by the air charged catheter
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Air Charged Catheter ARM Procedure
- DIAGNOSTIC_TEST Solid State Catheter ARM Procedure
Study Locations (3)
Georgia
- Augusta University Digestive Health Center - Augusta
Illinois
- Southwest Gastroenterology - New Lenox
Missouri
- Digestive Health Center of the Four States, LLC - Joplin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2025-01-09 |
| Est. Completion | 2026-01 |
What NCT06805240 shows while recruiting
NCT06805240 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Air Charged Catheter ARM Procedure is the first listed.
NCT06805240 reports a single indexed study location in Georgia, Illinois, Missouri.
Frequently Asked Questions
What is clinical trial NCT06805240 about?
NCT06805240 is a clinical study titled "EvaluatIng Normal Values for traditionaL anorectaL fUnction paraMeters With aIr Charged aNd Solid State HRAM catheTErs ("ILLUMINATE" Study)". The research study will be conducted to obtain baseline, or "normative" information to compare an air charged HRAM catheter to traditional solid catheter measures using the IAPWG standardized testing protocol and London classification.
What is the current status of trial NCT06805240?
This trial is currently recruiting. The enrollment target is 81 participants. The study started on 2025-01-09. Estimated completion is 2026-01.
What conditions does trial NCT06805240 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT06805240?
The interventions under investigation include: Air Charged Catheter ARM Procedure (DIAGNOSTIC_TEST), Solid State Catheter ARM Procedure (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06805240?
This trial is sponsored by Laborie Medical Technologies, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06805240 being conducted?
This trial has 3 study locations across Georgia, Illinois, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06805240's enrollment target sits among peer trials
81 273rd of 1090 higher than 818 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI